0
0
0
0
1
2
3
$0
Is MicroStrategy solid or fragile? The Finex Financial Health Scanner reads MSTR's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $477.2M |
|---|---|
| Net income | -$3.8B |
| Operating margin | -1140.8% |
| Net margin | -806.3% |
| Cash and investments | $2.3B |
| Total debt | $8.2B |
| Free cash flow | -$3.2B |
| Revenue growth (1 year) | 3.0% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.